Drug Discovery 2026 (ELRIG)
London, UK
October 14, 2026 – October 15, 2026

SciLeads at Drug Discovery 2026
We’re excited to announce that SciLeads will be attending Drug Discovery 2026, the flagship event from ELRIG.
Celebrating its 20th anniversary this year, the conference returns to ExCeL London, cementing its status as Europe’s largest drug discovery and life sciences conference. We are looking forward to connecting with the global drug discovery community to discuss the latest innovations, breakthroughs, and collaborative efforts driving the sector forward.
Drug Discovery 2026 is a must-attend event for professionals across the life sciences spectrum, from early-career researchers to senior industry leaders. Spanning two days, the event provides a unique, free-to-attend forum where attendees can engage with 14 scientific tracks, explore an extensive exhibition hall featuring over 250 product and service suppliers, and participate in invaluable networking sessions. Whether you are interested in AI-driven discovery, bioconjugation, or the latest in cell-based models, this is the premier destination to shape the future of medicinal research.
About Drug Discovery 2026
Drug Discovery 2026 is the 20th annual meeting hosted by ELRIG, a not-for-profit, volunteer-led organization dedicated to the global drug discovery community. The event focuses on the intersection of academic and industry science, featuring contributions from partners such as SLAS, CRUK, The Microbiology Society, the British Neuroscience Association, and the Royal Society of Chemistry.
The agenda is designed to foster collaboration, featuring a mix of high-profile keynote sessions, technical presentations, an expansive exhibition floor, and dedicated spaces for early-career professionals, including “Network Like a Boss” and “Mini DD” sessions. The conference is committed to inclusivity, offering a free-to-attend model with dedicated quiet, family, and faith rooms to ensure all attendees can participate fully in the scientific discourse.
Key Details for Drug Discovery 2026
- Location: ExCeL London, Royal Victoria Dock, 1 Western Gateway, London, E16 1XL, United Kingdom
- Dates: 14 October 2026 – 15 October 2026
- Event Program: View the official conference program here
Quick Links for Drug Discovery 2026
Deadlines for Drug Discovery 2026
- October 13, 2026: Deadline for submitting titles and abstracts for flash poster presentations.
- October 20, 2026: Deadline for submitting titles and abstracts for general poster display.
- Note: Please check the official ELRIG portal regularly for updates on registration deadlines and specific session sign-up requirements.
Key Topics and Speakers for Drug Discovery 2026
- Keynote Speakers: Dr. Sam Barrell CBE (LifeArc); Panel discussions featuring Dr. Anne Phelan (GSK), Dr. Jason Mellad (OtoImmune), Prof. Sir Mene Pangalos (AstraZeneca), and Prof. Raghib Ali OBE (Our Future Health). View the speakers here.
- Next-Generation Biophysics: Advanced structural and physical analysis for discovery.
- AI in Compound Discovery and Experimental Design: Integrating machine learning into the R&D pipeline.
- Bioconjugation Approaches in Oncology: Enhancing therapeutic specificity and delivery.
- Cell-Based Models: Engineering the cell microenvironment and 3D biology.
- Microbes to Medicines: Leveraging microbiology for therapeutic development.
- Multiomics: Integrating large-scale biological datasets for target validation.
- Translational Innovation: Bridging the gap between early discovery and clinical application.
Who Attends Drug Discovery 2026
- Drug Discovery Scientists & Medicinal Chemists
- Academic Researchers & Principal Investigators
- Biotech & Pharmaceutical Industry Executives
- Early-Career Professionals (ECPs) and Students
- Data Scientists & AI/Machine Learning Specialists in Life Sciences
- Laboratory Managers & Automation Specialists
- Clinical Research Professionals
- Product & Service Suppliers to the Life Science Sector
“SciLeads has been critical to the success of our sales and marketing efforts. I don't know where we would be without its data and insights.”